주메뉴 바로가기 본문 바로가기

경동제약 로고

Products

Company credited for technology, KyungDong Pharm

View Product

Inhipla Tab.

  • Brand name Inhipla Tab.
  • Category Cardiovascular
  • Active Ingredient Clopidogrel bisulfate
  • Rx/OTC Rx
Active Ingredient
Clopidogrel bisulfate 97.875mg
(Clopidogrel 75mg)



Indication
1. Improvement of atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction or peripheral arterial disease
2. Improvement of atherosclerotic symptoms (death due to cardiovascular abnormalities, myocardial infarction, stroke or refractory ischemia) in adult patients with acute coronary syndrome[Including patients who have undergone drug treatment or coronary intervention (PCI) (with or without stent) and coronary artery bypass grafting (CABG) in patients with unstable angina or non-Q wave myocardial infarction]
3. Reducing the risk of atherosclerosis and thromboembolism, including stroke, in adult patients with atrial fibrillation who have one or more vascular risk factors, are not suitable for vitamin K antagonist (VKA) administration, and have low bleeding risk


Dosage & Administration
1. For patients with ischemic stroke, myocardial infarction or peripheral arterial disease: 75 mg once a day.
2. For patients with acute coronary syndrome (unstable angina pectoris or non-Q wave myocardial infarction): On the day of initiation take 300 mg as a loading dose, and then 75 mg once a day thereafter.
3. For patients with atrial fibrillation: 75 mg once a day.


Drug Class
Antithrombotics

LIST